Current Issue
Commentary
The Use of Hydroxychloroquine and Interferons for the Prophylaxis of COVID-19
Arch Pharmacol Ther, 2021, 3, 1 - 4
Catherine Teng, Moses Shrestha, Bing Yang
[DOI No.: https://doi.org/10.33696/Pharmacol.3.019]
Editorial
COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer
Arch Pharmacol Ther, 2021, 3, 5 - 9
Daniel A. King, Jeffrey Chi, Shreya Prasad Goyal, M. Wasif Saif
[DOI No.: https://doi.org/10.33696/Pharmacol.3.020]
Brief Report
COVID-19 and the Health of Illicit Substance Users: Preliminary Analysis from Illicit Drug Transaction Data
Arch Pharmacol Ther, 2021, 3, 10 - 13
Andréanne Bergeron, David Décary-Hétu
[DOI No.: https://doi.org/10.33696/Pharmacol.3.021]
Research Article
COVID-19 Rapid Diagnostic Test Results and their Associations with Certain Factors Among the Residents of Balochistan
Arch Pharmacol Ther, 2021, 3, 14 - 20
Ehsan Larik, Muhammad Arif, Abid Saeed, Zirza Amir Baig, Zakir Hussain, Ambreen Chaudhary, Mirza Zeeshan Iqbal Baig, Zubair Bugti, Jan Inayat, Khair Muhammad, Muhammad Abdullah, Zubair Ahmed Khoso, Qurat-ul- ain, Aftab Kakar, Nasir Sheikh
[DOI No.: https://doi.org/10.33696/Pharmacol.3.022]
Research Article
Clerodendrum Chinensis Extracts; AeC and EeC Exerts Rapid Antihypertensive Effects in L-NAME Hypertensive Experimental Models
Arch Pharmacol Ther, 2021, 3, 21 - 28
Joy I. Odimegwu, Tolulope F. Okanlawon, Noel Obumneme, Ismail Ishola